Details of Drug

Drug General Information (ID: D0829)
Drug Name	Iobenguane (I-131)
Drug Type	Small molecule
Drug Synonymous	Iobenguane; 80663-95-2; m-Iodobenzylguanidine; Metaiodobenzylguanidine; meta-Iodobenzylguanidine; 3-Iodobenzylguanidine; 2-[(3-iodophenyl)methyl]guanidine; UNII-35MRW7B4AD; MIBG; Guanidine, ((3-iodophenyl)methyl)-; 139755-80-9; Guanidine,N-[(3-iodophenyl)methyl]-; 2-(3-Iodobenzyl)guanidine; 35MRW7B4AD; (3-Iodobenzyl)guanidine; NCGC00015572-04; SR-01000075167; Prestwick-07A11; starbld0001019; Iobenguane (127-i); meta-iodobenzyl guanidine; Prestwick0_000490; Prestwick1_000490; Prestwick2_000490; Prestwick3_000490; Lopac-I-9890; 2-m-iodo-benzyl guanidine; CHEMBL818; 1-(3-Iodobenzyl)guanidine; Lopac0_000644; BSPBio_000359; SCHEMBL140591; SPBio_002280; BPBio1_000395; ((3-iodophenyl)methyl)guanidine; DTXSID4048438; CHEBI:92769; 1-[(3-iodophenyl)methyl]guanidine; ZINC1538318; CCG-204731; DB06704; SDCCGSBI-0050624.P002; NCGC00015572-01; NCGC00015572-02; NCGC00015572-03; NCGC00015572-06; NCGC00015572-09; NCGC00162211-01; DA-02654; Q3154058; SR-01000075167-1; BRD-K43860855-065-03-6 Click to Show/Hide
Therapeutic Class	Therapeutic Radiopharmaceuticals
Structure
Structure	3D Structure		2D Structure
Formula	C8H10IN3
InChI	InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)
InChIKey	PDWUPXJEEYOOTR-UHFFFAOYSA-N
Canonical SMILES	C1=CC(=CC(=C1)I)CN=C(N)N
External Link
External Link	Pubchem ID	60860

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM003 Affected organization distribution AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM014 Interference of cell/tissue uptake BM027 Decreased renal excretion due to nephrotoxicity BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM072 Increased risk of nephrotoxicity BM100 Antagonize the effect of vaccine/toxoid BM105 Antagonize the effect of probiotics BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Iobenguane (I-131)
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 81
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0068		Amitriptyline	C20H23N	2160	Major		Inter Info	[4]
D0072		Amoxapine	C17H16ClN3O	2170	Major		Inter Info	[4]
D0074		Amphetamine	C9H13N	3007	Major		Inter Info	[4]
D0165		Benzphetamine	C17H21N	5311017	Major		Inter Info	[4]
D0200		Bretylium	C11H17BrN+	2431	Major		Inter Info	[4]
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[4]
D0265		Carteolol	C16H24N2O3	2583	Major		Inter Info	[4]
D0266		Carteolol (ophthalmic)	C16H24N2O3	2583	Major		Inter Info	[4]
D0267		Carvedilol	C24H26N2O4	2585	Major		Inter Info	[4]
D0361		Clomipramine	C19H23ClN2	2801	Major		Inter Info	[4]
D0378		Cocaine (topical)	C17H21NO4	446220	Major		Inter Info	[4]
D0444		Deserpidine	C32H38N2O8	8550	Major		Inter Info	[4]
D0446		Desipramine	C18H22N2	2995	Major		Inter Info	[4]
D0451		Desvenlafaxine	C16H25NO2	125017	Major		Inter Info	[4]
D0457		Dexfenfluramine	C12H16F3N	66265	Major		Inter Info	[4]
D0465		Dextroamphetamine	C9H13N	5826	Major		Inter Info	[4]
D0486		Diethylpropion	C13H19NO	7029	Major		Inter Info	[4]
D0517		Dopamine	C8H11NO2	681	Major		Inter Info	[4]
D0523		Doxapram	C24H30N2O2	3156	Major		Inter Info	[4]
D0525		Doxepin	C19H21NO	667477	Major		Inter Info	[4]
D0526		Doxepin (topical)	C19H21NO	667477	Major		Inter Info	[4]
D0539		Duloxetine	C18H19NOS	60835	Major		Inter Info	[4]
D0579		Ephedrine	C10H15NO	9294	Major		Inter Info	[4]
D0580		Ephedrine (nasal)	C10H15NO	9294	Major		Inter Info	[4]
D0593		Ergotamine	C33H35N5O5	8223	Major		Inter Info	[4]
D0641		Fenfluramine	C12H16F3N	3337	Major		Inter Info	[4]
D0743		Guanadrel	C10H19N3O2	38521	Major		Inter Info	[4]
D0744		Guanethidine	C10H22N4	3518	Major		Inter Info	[4]
D0795		Imipramine	C19H24N2	3696	Major		Inter Info	[4]
D0920		Levomilnacipran	C15H22N2O	6917779	Major		Inter Info	[4]
D1036		Methylene blue	C16H18ClN3S	6099	Major		Inter Info	[4]
D1107		Naphazoline (nasal)	C14H14N2	4436	Major		Inter Info	[4]
D1108		Naphazoline (ophthalmic)	C14H14N2	4436	Major		Inter Info	[4]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[4]
D1358		Propylhexedrine (nasal)	C10H21N	7558	Major		Inter Info	[4]
D1567		Tetryzoline (nasal)	C13H16N2	5419	Major		Inter Info	[4]
D1568		Tetryzoline (ophthalmic)	C13H16N2	5419	Major		Inter Info	[4]
D0853		Isocarboxazid	C12H13N3O2	3759	Major		Inter Info	[4]
D0884		Labetalol	C19H24N2O3	3869	Major		Inter Info	[4]
D0933		Linezolid	C16H20FN3O4	441401	Major		Inter Info	[4]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Major		Inter Info	[4]
D0979		Maprotiline	C20H23N	4011	Major		Inter Info	[4]
D0981		Mazindol	C16H13ClN2O	4020	Major		Inter Info	[4]
D1002		Mephentermine	C11H17N	3677	Major		Inter Info	[4]
D1012		Metamfetamine	C10H15N	10836	Major		Inter Info	[4]
D1013		Metaraminol	C9H13NO2	5906	Major		Inter Info	[4]
D1039		Methylphenidate	C14H19NO2	4158	Major		Inter Info	[4]
D1061		Midodrine	C12H18N2O4	4195	Major		Inter Info	[4]
D1066		Milnacipran	C15H22N2O	65833	Major		Inter Info	[4]
D1158		Nortriptyline	C19H21N	4543	Major		Inter Info	[4]
D1204		Oxymetazoline (nasal)	C16H24N2O	4636	Major		Inter Info	[4]
D1205		Oxymetazoline (ophthalmic)	C16H24N2O	4636	Major		Inter Info	[4]
D1244		Penbutolol	C18H29NO2	37464	Major		Inter Info	[4]
D1262		Phendimetrazine	C12H17NO	30487	Major		Inter Info	[4]
D1263		Phenelzine	C8H12N2	3675	Major		Inter Info	[4]
D1270		Phentermine	C10H15N	4771	Major		Inter Info	[4]
D1276		Phenylephrine	C9H13NO2	6041	Major		Inter Info	[4]
D1277		Phenylephrine (nasal)	C9H13NO2	6041	Major		Inter Info	[4]
D1278		Phenylephrine (ophthalmic)	C9H13NO2	6041	Major		Inter Info	[4]
D1280		Phenylephrine (topical)	C9H13NO2	6041	Major		Inter Info	[4]
D1281		Phenylpropanolamine	C9H13NO	26934	Major		Inter Info	[4]
D1293		Pindolol	C14H20N2O2	4828	Major		Inter Info	[4]
D1345		Procarbazine	C12H19N3O	4915	Major		Inter Info	[4]
D1357		Propranolol	C16H21NO2	4946	Major		Inter Info	[4]
D1361		Protriptyline	C19H21N	4976	Major		Inter Info	[4]
D1363		Pseudoephedrine	C10H15NO	7028	Major		Inter Info	[4]
D1385		Rasagiline	C12H13N	3052776	Major		Inter Info	[4]
D1393		Reserpine	C33H40N2O9	5770	Major		Inter Info	[4]
D1437		Safinamide	C17H19FN2O2	131682	Major		Inter Info	[4]
D1455		Selegiline	C13H17N	26757	Major		Inter Info	[4]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[4]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[4]
D1535		Tapentadol	C14H23NO	9838022	Major		Inter Info	[4]
D1585		Timolol	C13H24N4O3S	33624	Major		Inter Info	[4]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Major		Inter Info	[4]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[4]
D1620		Tranylcypromine	C9H11N	19493	Major		Inter Info	[4]
D1647		Trimipramine	C20H26N2	5584	Major		Inter Info	[4]
D1689		Venlafaxine	C17H27NO2	5656	Major		Inter Info	[4]
D1712		Xylometazoline (nasal)	C16H24N2	5709	Major		Inter Info	[4]
D1713		Yohimbine	C21H26N2O3	8969	Major		Inter Info	[4]
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0576		Entecavir	C12H15N5O3	135398508	Moderate		Inter Info	[51]
D0668		Flucytosine	C4H4FN3O	3366	Moderate		Inter Info	[55]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[6], [74], [75]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[80]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[84]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[86]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 39
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Major		Inter Info	[1], [2], [3]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[6], [7]
D0614		Etanercept	NA	NA	Major		Inter Info	[1], [2], [3]
D0736		Golimumab	NA	NA	Major		Inter Info	[1], [2], [3]
D0802		Infliximab	NA	NA	Major		Inter Info	[1], [2], [3]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[22], [6], [23]
D0304		Certolizumab pegol	NA	NA	Major		Inter Info	[1], [2], [3]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[26]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[22], [28]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[32], [33]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[34]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[35]
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[32], [33]
D1111		Natalizumab	NA	NA	Major		Inter Info	[36]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[29], [38], [39]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[40], [39]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[41], [42], [43]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[22], [6], [39]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[41], [42], [43]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[22], [6], [47]
D0314		Chloramphenicol (ophthalmic)	C11H12Cl2N2O5	5959	Moderate		Inter Info	[22], [6], [47]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[39], [49]
D0553		Efalizumab	NA	NA	Moderate		Inter Info	[50]
D0499		Dimethyl fumarate	C6H8O4	637568	Moderate		Inter Info	[68]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[68]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[68]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[70]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[71]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[6], [72]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[73]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[76]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[22], [6], [77]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[79]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[81]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[41], [42], [43]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[6], [85]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[87]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[88]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[22], [6], [89]
	Additive myelosuppressive effects					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[22], [24], [25]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[37]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[22], [6], [56]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[22], [6], [56]
	Increased risk of nephrotoxicity					Drug Num: 30
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0335		Cidofovir	C8H14N3O6P	60613	Major		Inter Info	[5]
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[8], [9]
D0472		Diatrizoate	C11H9I3N2O4	2140	Major		Inter Info	[10], [11], [12]
D0629		Everolimus	C53H83NO14	6442177	Major		Inter Info	[13], [14], [15]
D0765		Human immunoglobulin G (intravenous)	NA	NA	Major		Inter Info	[16], [17], [18]
D0761		Human botulinum neurotoxin A/B immune globulin	NA	NA	Major		Inter Info	[16], [17], [18]
D0763		Human cytomegalovirus immune globulin	NA	NA	Major		Inter Info	[16], [17], [18]
D0768		Human Rho(D) immune globulin	NA	NA	Major		Inter Info	[16], [17], [18]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Major		Inter Info	[6], [27]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[10], [11], [12]
D0836		Iopromide	C18H24I3N3O8	3736	Major		Inter Info	[10], [11], [12]
D0837		Iothalamic acid	C11H9I3N2O4	3737	Major		Inter Info	[10], [11], [12]
D0838		Ioversol	C18H24I3N3O9	3741	Major		Inter Info	[10], [11], [12]
D0839		Ioxilan	C18H24I3N3O8	3743	Major		Inter Info	[10], [11], [12]
D0831		Iodipamide	C20H14I6N2O6	3739	Major		Inter Info	[10], [11], [12]
D0832		Iodixanol	C35H44I6N6O15	3724	Major		Inter Info	[10], [11], [12]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[10], [11], [12]
D1476		Sirolimus	C51H79NO13	5284616	Major		Inter Info	[13], [14], [15]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[13], [14], [15]
D1549		Temsirolimus	C56H87NO16	6918289	Major		Inter Info	[13], [14], [15]
D0145		Balsalazide	C17H15N3O6	54585	Moderate		Inter Info	[44], [45], [46]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[48]
D0421		Daptomycin	C72H101N17O26	16134395	Moderate		Inter Info	[6]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[57], [58], [59]
D1009		Mesalazine	C7H7NO3	4075	Moderate		Inter Info	[44], [45], [46]
D1030		Methoxyflurane	C3H4Cl2F2O	4116	Moderate		Inter Info	[6]
D1173		Olsalazine	C14H10N2O6	22419	Moderate		Inter Info	[44], [45], [46]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[57], [58], [59]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[44], [45], [46]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[57], [58], [59]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[69]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1744		Bacillus calmette-guerin substrain tice live antigen	NA	NA	Major		Inter Info	[19], [20], [21]
D1839		Measles virus vaccine live attenuated	NA	NA	Major		Inter Info	[19], [20], [21]
D1849		Mumps virus strain B level jeryl lynn live antigen	NA	NA	Major		Inter Info	[19], [20], [21]
D1881		Rotavirus vaccine	NA	NA	Major		Inter Info	[19], [20], [21]
D1882		Rubella virus vaccine	NA	NA	Major		Inter Info	[19], [20], [21]
D1890		Smallpox (Vaccinia) Vaccine, Live	NA	NA	Major		Inter Info	[29], [22], [30]
D1897		Talimogene laherparepvec	NA	NA	Major		Inter Info	[31]
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[19], [20], [21]
D1920		Varicella Zoster Vaccine (Recombinant)	NA	NA	Major		Inter Info	[19], [20], [21]
D1922		Yellow Fever Vaccine	NA	NA	Major		Inter Info	[19], [20], [21]
D0089		Anthrax vaccine	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0366		Clostridium tetani toxoid antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0755		Hepatitis A Vaccine	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0756		Hepatitis B Vaccine (Recombinant)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0767		Human papillomavirus type 11 L1 capsid protein antigen	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0803		Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0804		Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D0999		Meningococcal polysaccharide vaccine group C	NA	NA	Moderate		Inter Info	[29], [60], [61]
D1259		Pfizer-BioNTech Covid-19 Vaccine	NA	NA	Moderate		Inter Info	[29], [60], [61]
D1307		Poliovirus type 1 antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D1662		Typhoid vaccine (inactivated)	NA	NA	Moderate		Inter Info	[29], [60], [61]
D1692		Vibrio cholerae CVD 103-HgR strain live antigen	NA	NA	Moderate		Inter Info	[29], [60], [61]
D1838		Lyme disease vaccine (recombinant OspA)	NA	NA	Moderate		Inter Info	[78]
	Antagonize the effect of probiotics					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1749		Bifidobacterium longum infantis	NA	NA	Moderate		Inter Info	[62], [63], [64]
D1827		Lactobacillus acidophilus	NA	NA	Moderate		Inter Info	[62], [63], [64]
	Diminish the response to diagnostic skin test antigens					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1755		Candida albicans	C29H27N2O12P	118855431	Moderate		Inter Info	[65], [66], [67]
D1765		Coccidioides immitis spherule	NA	NA	Moderate		Inter Info	[65], [66], [67]
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[65], [66], [67]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[65], [66], [67]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[52], [53], [54]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[82], [83]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[52], [53], [54]

References
1	Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
3	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
4	Product Information. Azedra (iobenguane I-131). Progenics Pharmaceuticals, Inc., New York, NY.
5	Product Information. Vistide (cidofovir). Gilead Sciences, Foster City, CA.
6	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
7	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
8	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
9	Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M "Fanconi Syndrome Due to Deferasirox." Am J Kidney Dis (2009):. [PMID: 19493602]
10	Bentley ML, Corwin HL, Dasta J "Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies." Crit Care Med 38(6 Suppl) (2010): S169-74. [PMID: 20502171]
11	Dubrovskaya Y, Prasad N, Lee Y, Esaian D, Figueroa DA, Tam VH "Risk factors for nephrotoxicity onset associated with polymyxin B therapy." J Antimicrob Chemother 70 (2015): 1903-7. [PMID: 25652747]
12	Kellum JA, Leblanc M, Venkataraman R "Acute renal failure." BMJ Clin Evid 9 (2008): 2001. [PMID: 19445797]
13	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
14	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
15	Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM "Acute renal, failure associated with the use of ibuprofen in two liver transplant recipients on FK506." Transplantation 57 (1994): 1132-3. [PMID: 7513099]
16	Guo X, Nzerue C "How to prevent, recognize, and treat drug-induced nephrotoxicity.".
17	Centers for Disease Control and Prevention (CDC). Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.?MMWR Morb Mortal Wkly Rep. 1999;48(24):518-521. [PMID: 10401909]
18	Product Information. BabyBIG (botulism immune globulin). FFF Enterprises, Temecula, CA.
19	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
20	Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
21	Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
22	Cerner Multum, Inc. "Australian Product Information.".
23	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
24	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
25	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
26	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
27	Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
28	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
29	CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
30	Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
31	Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
32	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
33	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
34	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
35	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
36	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
37	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
38	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
39	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
40	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
41	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
42	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
43	Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
44	Product Information. Canasa (mesalamine (5-aminosalicylic acid)). Axcan Scandipharm Inc, Birmingham, AL.
45	Product Information. Lialda (mesalamine (5-aminosalicylic acid)). Shire US Inc, Florence, KY.
46	Schreiber S. Hamling J, Zehnter E, et al "Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate." Gut 40 (1997): 761-6. [PMID: 9245930]
47	Sim SM, Back DJ, Breckenridge AM "The effect of various drugs on the glucuronidation of zidovudine (azidothymidine AZT) by human liver microsomes." Br J Clin Pharmacol 32 (1991): 17-21. [PMID: 1909542]
48	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
49	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
50	Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
51	Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
52	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
53	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
54	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
55	Product Information. Ancobon (flucytosine). Roche Laboratories, Nutley, NJ.
56	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
57	Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
58	Kanis JA, Preston CJ, Yates AJ, Percival RC, Mundy KI, Russell RG "Effects of intravenous diphosphonates on renal function." Lancet 1 (1983): 1328. [PMID: 6134112]
59	Product Information. Zometa (zoledronic acid). Novartis Pharmaceuticals, East Hanover, NJ.
60	Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
61	Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
62	Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
63	Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
64	Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
65	Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
66	Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
67	Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
68	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
69	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
70	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
71	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
72	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
73	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
74	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
75	Gilead Sciences, Inc "About Remdesivir.".
76	AnazaoHealth Corporation "P32 Sodium Phosphate."
77	Multum Information Services, Inc. Expert Review Panel.
78	Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
79	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
80	Product Information. Eloxatin (oxaliplatin). Sanofi Winthrop Pharmaceuticals, New York, NY.
81	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
82	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
83	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
84	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
85	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
86	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
87	Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
88	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
89	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence